The Wexford Group Internationa, a CACI Company, Wins Share of $494 Million Prime Contract

The Wexford Group International, a wholly owned subsidiary of CACI International Inc, has announced the award of a five-year prime contract continuing its support of the Joint Improvised Explosive Device Defeat Organization (JIEDDO). Under the contract, Wexford will support JIEDDO with strategic planning, operational and training support, intelligence analysis, program management support, and strategic communications.  This latest award is one of five for the Indefinite Delivery/Indefinite Quantity (ID/IQ) contract, which is valued at $494 million.

JIEDDO is the DoD’s lead effort in defeating Improvised Explosive Devices (IEDs), with a three-pronged strategy of attack: assault the network, defeat the device, and train the force. JIEDDO teams with all Armed Services, the Intelligence Community, interagency organizations, and public, private and international partners.

Paul Cofoni, CACI President and CEO, said of this latest award “We are very pleased that the Wexford Group International can, once again, make a vital contribution to helping JIEDDO safeguard our warfighters. This is a significant contract that further solidifies CACI’s government partnership through which we provide high-quality, leading edge services in support of the nation’s defense.”

Bill Fairl, CACI President of U.S. Operations, added “This work with the Joint Improvised Explosive Device Defeat Organization offers CACI an exceptional opportunity to continue our significant support for this critically important Department of Defense organization. We’re extremely proud of our employees who help JIEDDO accomplish its mission of defeating threats to our nation’s service members serving in harm’s way.”

Check Also

Pentagon

Washington Headquarters Services Issues RFP for Acquisition Directorate Support Recompete

The Washington Headquarters Services has kicked off solicitations for the recompete of a multiple-award, indefinite-delivery/indefinite-quantity contract for analytic and technical support services to the WHS' acquisition directorate.

Liz Porter Health Group President Leidos

Leidos Promotes Liz Porter to Health Group President

Liz Porter, acting president of Leidos’ (NYSE: LDOS) health group since March, has been promoted to the position on a permanent basis. She will report directly to Roger Krone, chairman and CEO of Leidos and a 2020 Wash100 Award recipient.